192 related articles for article (PubMed ID: 28222771)
1. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway.
Wu X; Liu P; Zhang H; Li Y; Salmani JM; Wang F; Yang K; Fu R; Chen Z; Chen B
BMC Cancer; 2017 Feb; 17(1):147. PubMed ID: 28222771
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
[TBL] [Abstract][Full Text] [Related]
3. Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling.
Zhao K; Song X; Huang Y; Yao J; Zhou M; Li Z; You Q; Guo Q; Lu N
Eur J Pharmacol; 2014 Aug; 737():57-69. PubMed ID: 24858369
[TBL] [Abstract][Full Text] [Related]
4. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
[TBL] [Abstract][Full Text] [Related]
5. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
7. LMP1 promotes nasal NK/T-cell lymphoma cell function by eIF4E via NF-κB pathway.
Sun L; Zhao Y; Shi H; Ma C; Wei L
Oncol Rep; 2015 Dec; 34(6):3264-71. PubMed ID: 26397141
[TBL] [Abstract][Full Text] [Related]
8. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
[TBL] [Abstract][Full Text] [Related]
9. Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax.
Zhang M; Liu LP; Chen Y; Tian XY; Qin J; Wang D; Li Z; Mo SL
Life Sci; 2013 Jan; 92(1):55-62. PubMed ID: 23142241
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.
Abd El-Hafeez AA; Khalifa HO; Mahdy EAM; Sharma V; Hosoi T; Ghosh P; Ozawa K; Montano MM; Fujimura T; Ibrahim ARN; Abdelhamid MAA; Pack SP; Shouman SA; Kawamoto S
Pharmacol Rep; 2019 Apr; 71(2):289-298. PubMed ID: 30826569
[TBL] [Abstract][Full Text] [Related]
11. An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells.
Dewan MZ; Tomita M; Katano H; Yamamoto N; Ahmed S; Yamamoto M; Sata T; Mori N; Yamamoto N
Int J Cancer; 2009 Feb; 124(3):622-9. PubMed ID: 18973272
[TBL] [Abstract][Full Text] [Related]
12. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
13. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63.
Chow SE; Chang YL; Chuang SF; Wang JS
Cancer Chemother Pharmacol; 2011 Oct; 68(4):835-45. PubMed ID: 21207227
[TBL] [Abstract][Full Text] [Related]
14. Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF‑κB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling.
Liu X; Tian S; Liu M; Jian L; Zhao L
Int J Mol Med; 2016 Oct; 38(4):1250-6. PubMed ID: 27499272
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death.
Shan X; Tian LL; Zhang YM; Wang XQ; Yan Q; Liu JW
Int J Oncol; 2015 Aug; 47(2):701-9. PubMed ID: 26094873
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.
Thompson RC; Herscovitch M; Zhao I; Ford TJ; Gilmore TD
J Biol Chem; 2011 Jan; 286(3):1675-82. PubMed ID: 20947507
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.
Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS
Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817
[TBL] [Abstract][Full Text] [Related]
18. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines.
Rahadiani N; Takakuwa T; Tresnasari K; Morii E; Aozasa K
Biochem Biophys Res Commun; 2008 Dec; 377(2):579-583. PubMed ID: 18926796
[TBL] [Abstract][Full Text] [Related]
19. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
Kim HR; Park CG; Jung JY
Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of the canonical NF-κB signaling pathway in EBV-associated gastric carcinoma.
Zhang Y; Liu W; Zhang W; Wang W; Song Y; Xiao H; Luo B
Virology; 2019 Jun; 532():1-10. PubMed ID: 30974373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
